The global patient controlled analgesia pumps market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market can be attributed to the increasing number of surgeries and rising geriatric population in developing countries such as India and China.
PCA Pumps are used for continuous administration of analgesics or sedatives through an infusion pump, which is connected to a catheter inserted into the patient's epidural space or subarachnoid space. PCA pumps are used in hospitals, ambulatory surgical centers, home care settings, and clinics for post-operative pain management. The PCA Pumps segment accounted for over 50% share in 2017 owing to its wide range of applications across various healthcare settings such as hospitals and ambulatory surgical centers where patients require continuous administration of analgesics or sedatives after surgery.
North America dominated the global patient controlled analgesia pumps market with over 40% share in 2017 due to high adoption rates among hospitals and ambulatory surgical centers in this region coupled with favorable reimbursement policies from government authorities such as Medicare/Medicaid programs that provide reimbursement for these devices on a cost-plus basis without any deductibles or co-payments from patients.
Some Of The Growth Factors Of This Market:
- The increasing number of patients suffering from chronic pain is a major factor driving the growth of the patient-controlled analgesia pumps market.
- The rising geriatric population is also a major factor driving the growth of the patient-controlled analgesia pumps market.
- Increasing awareness about pain management and its benefits among physicians and patients is also a major factor driving the growth of the patient-controlled analgesia pumps market.
- Increasing prevalence rates for chronic diseases such as cancer, diabetes, and arthritis are also factors that are expected to drive the growth of this market in future years.
- Rising healthcare expenditure by governments across various countries is another factor that will drive this market in future years.
Industry Growth Insights published a new data on “Patient-Controlled Analgesia Pumps Market”. The research report is titled “Patient-Controlled Analgesia Pumps Market research by Types (PCA Pumps, Pump Accessories), By Applications (Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics, Others), By Players/Companies Smiths Group, Fresenius Kabi Group, Hospira (Pfizer Inc.), Micrel Medical Devices, Ace Medical Co. Ltd., Terumo Corporation, B.Braun Melsungen AG, Baxter International, Becton Dickinson and Company”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Patient-Controlled Analgesia Pumps Market Research Report
By Type
PCA Pumps, Pump Accessories
By Application
Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics, Others
By Companies
Smiths Group, Fresenius Kabi Group, Hospira (Pfizer Inc.), Micrel Medical Devices, Ace Medical Co. Ltd., Terumo Corporation, B.Braun Melsungen AG, Baxter International, Becton Dickinson and Company
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Patient-Controlled Analgesia Pumps Market Report Segments:
The global Patient-Controlled Analgesia Pumps market is segmented on the basis of:
Types
PCA Pumps, Pump Accessories
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Smiths Group
- Fresenius Kabi Group
- Hospira (Pfizer Inc.)
- Micrel Medical Devices
- Ace Medical Co. Ltd.
- Terumo Corporation
- B.Braun Melsungen AG
- Baxter International
- Becton Dickinson and Company
Highlights of The Patient-Controlled Analgesia Pumps Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- PCA Pumps
- Pump Accessories
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Home Care Settings
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Patient-Controlled Analgesia Pumps Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Patient-controlled analgesia pumps are medical devices that administer an opioid medication to a patient in order to relieve pain.
Some of the major companies in the patient-controlled analgesia pumps market are Smiths Group, Fresenius Kabi Group, Hospira (Pfizer Inc.), Micrel Medical Devices, Ace Medical Co. Ltd., Terumo Corporation, B.Braun Melsungen AG, Baxter International, Becton Dickinson and Company.
The patient-controlled analgesia pumps market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Patient-Controlled Analgesia Pumps Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Patient-Controlled Analgesia Pumps Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Patient-Controlled Analgesia Pumps Market - Supply Chain
4.5. Global Patient-Controlled Analgesia Pumps Market Forecast
4.5.1. Patient-Controlled Analgesia Pumps Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Patient-Controlled Analgesia Pumps Market Size (000 Units) and Y-o-Y Growth
4.5.3. Patient-Controlled Analgesia Pumps Market Absolute $ Opportunity
5. Global Patient-Controlled Analgesia Pumps Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Patient-Controlled Analgesia Pumps Market Size and Volume Forecast by Type
5.3.1. PCA Pumps
5.3.2. Pump Accessories
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Patient-Controlled Analgesia Pumps Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Patient-Controlled Analgesia Pumps Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Centers
6.3.3. Home Care Settings
6.3.4. Clinics
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Patient-Controlled Analgesia Pumps Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Patient-Controlled Analgesia Pumps Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Patient-Controlled Analgesia Pumps Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Patient-Controlled Analgesia Pumps Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Patient-Controlled Analgesia Pumps Demand Share Forecast, 2019-2026
9. North America Patient-Controlled Analgesia Pumps Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Patient-Controlled Analgesia Pumps Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Patient-Controlled Analgesia Pumps Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Ambulatory Surgical Centers
9.4.3. Home Care Settings
9.4.4. Clinics
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Patient-Controlled Analgesia Pumps Market Size and Volume Forecast by Type
9.7.1. PCA Pumps
9.7.2. Pump Accessories
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Patient-Controlled Analgesia Pumps Demand Share Forecast, 2019-2026
10. Latin America Patient-Controlled Analgesia Pumps Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Patient-Controlled Analgesia Pumps Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Patient-Controlled Analgesia Pumps Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Home Care Settings
10.4.4. Clinics
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Patient-Controlled Analgesia Pumps Market Size and Volume Forecast by Type
10.7.1. PCA Pumps
10.7.2. Pump Accessories
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Patient-Controlled Analgesia Pumps Demand Share Forecast, 2019-2026
11. Europe Patient-Controlled Analgesia Pumps Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Patient-Controlled Analgesia Pumps Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Patient-Controlled Analgesia Pumps Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Home Care Settings
11.4.4. Clinics
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Patient-Controlled Analgesia Pumps Market Size and Volume Forecast by Type
11.7.1. PCA Pumps
11.7.2. Pump Accessories
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Patient-Controlled Analgesia Pumps Demand Share, 2019-2026
12. Asia Pacific Patient-Controlled Analgesia Pumps Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Patient-Controlled Analgesia Pumps Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Patient-Controlled Analgesia Pumps Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Home Care Settings
12.4.4. Clinics
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Patient-Controlled Analgesia Pumps Market Size and Volume Forecast by Type
12.7.1. PCA Pumps
12.7.2. Pump Accessories
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Patient-Controlled Analgesia Pumps Demand Share, 2019-2026
13. Middle East & Africa Patient-Controlled Analgesia Pumps Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Patient-Controlled Analgesia Pumps Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Patient-Controlled Analgesia Pumps Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Home Care Settings
13.4.4. Clinics
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Patient-Controlled Analgesia Pumps Market Size and Volume Forecast by Type
13.7.1. PCA Pumps
13.7.2. Pump Accessories
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Patient-Controlled Analgesia Pumps Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Patient-Controlled Analgesia Pumps Market: Market Share Analysis
14.2. Patient-Controlled Analgesia Pumps Distributors and Customers
14.3. Patient-Controlled Analgesia Pumps Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Smiths Group
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Fresenius Kabi Group
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Hospira (Pfizer Inc.)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Micrel Medical Devices
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Ace Medical Co. Ltd.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Terumo Corporation
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. B.Braun Melsungen AG
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Baxter International
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Becton Dickinson and Company
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
